Physician profile
Eric Verfaillie
NPI 1528368263
$1,132.53
in general payments reported to CMS, 2019-2025
17 companies · $405 in 2025
The $405 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $24.35 · 2023: $246 · 2024: $458 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,010 · Education: $98.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,010.18 |
| Education | $98.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $328.70 | 2023-2025 | |
| Seagen INC. | $98.00 | 2023 | |
| Csl Behring | $83.32 | 2023-2025 | Hemgenix, Idelvion |
| Alexion Pharmaceuticals, INC. | $82.23 | 2024-2025 | Ultomiris, Koselugo |
| Genetix Biotherapeutics INC | $80.06 | 2024-2025 | Lyfgenia |
| Novo Nordisk INC | $68.43 | 2023-2024 | Rebinyn, Novoseven, Novoeight |
| Adaptive Biotechnologies Corporation | $64.10 | 2024-2025 | Clonoseq |
| Servier Pharmaceuticals LLC | $58.96 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $49.64 | 2023-2025 | |
| Amgen INC. | $37.76 | 2022-2023 | Blincyto |
| Pfizer INC. | $35.26 | 2024 | |
| Boston Scientific Corporation | $29.48 | 2024 | Bodyguardian |
| Takeda Pharmaceuticals U.S.A., INC. | $26.34 | 2024 | Advate |
| Springworks Therapeutics, INC. | $25.07 | 2025 | |
| Biomarin Pharmaceutical INC. | $24.63 | 2024 | Roctavian |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $20.31 | 2024 | Hemlibra |
| Agios Pharmaceuticals, INC. | $20.24 | 2025 | Pyrukynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Verfaillie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.